Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

Merck chases Roche with triple-negative breast cancer data for Keytruda

Data demonstrated a delay in disease progression or death

- PMLiVE

The roaring ‘20s and Generation Z

How a new generation will shape pharma comms this decade

- PMLiVE

imc group appoints Amber Fensome to senior leadership position

Fensome brings over 20 years’ experience to the role

Love – it really does make the world go around

No two people are the same nor as individuals are we particularly predictable – we might like to think we are because at some point in time someone decided that...

Page & Page Health

OPEN Health supports Genetic Alliance UK’s Rare Film Festival!

OPEN Health joined a number of rare disease patients, patient groups and industry representatives at the Regent Street cinema in London to see the winners announced at the Rare Film...

OPEN Health

- PMLiVE

Janssen files new Darzalex combination for multiple myeloma

Expands use of anti-CD38 antibody even further

- PMLiVE

NICE turns down Keytruda/Inlyta combo for kidney cancer

Cost-effectiveness agency says the long-term benefit is uncertain

- PMLiVE

UPDATED: J&J expands US partnership for coronavirus treatments

Expands on exisiting alliance announced last week

- PMLiVE

Seattle Genetics makes case for Padcev plus Keytruda in first-line bladder cancer

Hopes to extend the antibody drug conjugate's use into the earlier setting

- PMLiVE

This isn’t goodbye, it’s see you in August!

Bedrock Group imagines, creates and delivers industry-leading benefits

Bedrock Healthcare Communications

- PMLiVE

Novartis plans inclisiran trial in the UK

Swiss pharma also officially opens new London headquarters

- PMLiVE

A market-adapted agile approach to launch excellence

By Suzie Denton

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links